Viewing Study NCT01496534


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-29 @ 4:46 AM
Study NCT ID: NCT01496534
Status: TERMINATED
Last Update Posted: 2013-11-27
First Post: 2011-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
Sponsor: Matthew Galsky
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module